Lunate Capital Limited
Lunate Capital Limited, managed by Mohamed Hassan Alsuwaidi, reported 10 positions worth $196.00M in its 2026 Q2 13F filing: 6 new and 2 closed.
Estimated return
Since 2025 Q2 the disclosed positions returned an estimated +144.1% against +34.4% for the S&P 500. Price-only return of the fund's top 100 US longs at each quarter start, vs the S&P 500 over the same windows. Not the fund's actual return (no trades, fees, shorts, derivatives, cash).
| Quarter | Fund | S&P 500 |
|---|---|---|
| 2025 Q2 | +3.4% | +11.4% |
| 2025 Q3 | +10.5% | +7.6% |
| 2025 Q4 | +30.8% | +3.1% |
| 2026 Q1 | +6.2% | -5.8% |
| 2026 Q2 | +53.8% | +15.5% |
Top holdings, 2026 Q2
| Ticker | Company | Value | Portfolio % | Change |
|---|---|---|---|---|
| SAIL | SAILPOINT INC | $43.92M | 22.40% | NO CHANGE |
| BIRK | BIRKENSTOCK HOLDING PLC | $43.46M | 22.20% | NEW |
| LINE | LINEAGE INC | $25.95M | 13.20% | NO CHANGE |
| BXSL | BLACKSTONE SECD LENDING FD | $23.73M | 12.10% | NEW |
| GSBD | GOLDMAN SACHS BDC INC | $20.78M | 10.60% | NEW |
| MSDL | MORGAN STANLEY DIRECT LENDIN | $16.69M | 8.50% | NEW |
| OBDC | BLUE OWL CAPITAL CORPORATION | $13.05M | 6.70% | NEW |
| NAVN | NAVAN INC | $4.57M | 2.30% | NO CHANGE |
| NMRA | NEUMORA THERAPEUTICS INC. | $3.61M | 1.80% | NO CHANGE |
| FIG | FIGMA INC | $240.42K | 0.12% | NEW |
All funds · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.